Compositions and methods for IL-13 biomarkers

Details Compositions and methods for IL-13 biomarkers Compositions and methods for IL-13 biomarkers

2011-01-25

2011-01-25

Skelding, Zachary (Department: 1644)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

07875427

ABSTRACT:
Compositions and methods are provided for measuring and determining biomarkers for IL-13.

REFERENCES:
patent: 5853697 (1998-12-01), Strober
patent: 6194163 (2001-02-01), Doyle et al.
patent: 2005/0036951 (2005-02-01), Henderson
patent: 1347051 (2003-09-01), None
patent: 1394274 (2004-03-01), None
Boutten et al., Thorax. Oct. 2004;59(10):850-4.
Gebauer et al., Nat Rev Mol Cell Biol. Oct. 2004;5(10):827-35.
Enric Espel, Semin Cell Dev Biol. Feb. 2005;16(1):59-67.
Piecyk et al., EMBO J. Aug. 1, 2000;19(15):4154-63.
Dejmek et al., Clin Cancer Res. Jan. 15, 2005;11(2 Pt 1):520-8.
Fan et al., Eur Respir J. Nov. 2005;26(5):933-47.
Kolls et al., Immunity. Oct. 2004;21(4):467-76.
Oshima et al., FASEB J. Jun. 2001;15(8):1469-71.
(1997) “National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma. Rep. No. 97-4051. Washington DC: US.Dept.Health Human Serv., Nat'l. Heart & Lung Blood Inst.”
(2001) “Biomarkers and Surrogate Endpoints: preferred definitions and conceptual framework”. Clin. Pharmacol Ther 69(3): 89-95.
Akbari O,S.P., Meyer E., Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, Dekruyff RH, Umetsu DT. (2003) “Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity”. Nat Med 9: 582-588.
Berkman, N.,S.Ohnona, et al. (2001). “Eotaxin-3 but Not Eotaxin Gene Expression is Upregulated in Asthmatics 24 Hours After Allergen Challenge”. Am.J. Respir.Cell.Mol.Biol. 24(6): 682-687.
Elias J, Z.A. Chupp G., Homer R. (1999) “Airway Remodeling in Asthma”. J Clin Invest 104(8): 1001-6.
Fahey, J. (2000) “Proceedings fo the ATS Workshop on Refactory Asthma: Current Understanding, Recommendations, and Unanswered Questions.” Am. J. Respi. Crt. Care Md. 162(6):341-6.
Grunig G, W.M. Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB. (1998). “Requirement for IL-13 Independently of IL-4 in Experimental Asthma”. Science 282: 2261-2263.
Hijnen, D, M. De Bruin-Weller et al., (2004). “Serum Thymus and Activation-regulated Chemokine (TARC) and Cutaneous T Cell-Attracting Chemokine (CTACK) Levels in Allergic Diseases: TARC and CTACK are disease-specific markers for atopic dermatitis”. Journal of Allergy and Clinical Immunology 113(2): 334-340.
Holgate, S. T. (1999) “The Epidemic of Allergy and Asthma”, Nature 402: B2-B4.
Leung, T.F., C.K. Wong, et al. (2003). “Plasma TARC Concentration may be a Useful Marker for Asthmatic Exacerbation in Children”. Eur Respir J 21(4): 616-620.
Pilette, C, J.N. Francis, et al. (2004). “CCR4 Ligands are Up-regulated in the Airways of Atopic Asthmatics after Segmental Allergen Challenge”. Eur Respir J 23(6): 876-884.
Sekiya T., “Increased Levels of the TH2-Type CC Chemokine Thymus and Activaton-Regulated Chemokine (TAC) in Serum and Induced Sputum of Asthmatics”, Allergy 2002 173-177.
Venkayya R, L.M., Willkom M, Grunig G, Corry DB, Erle DJ (2002). “The Th2 Lymphocyte Products IL-4 and IL-13 Rapidly Induce Airway Hyperresponsiveness through Direct Effects on Resident Airway Cells”. Am J Respir Cell Mol Biol. 26: 202-208.
Walter DM, M.J., Berry G, Mc Kenzie AN, Donaldson DD, Dekruyff RH, Umetsu DT. (2001). “Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity”. J Immunol 167: 4668-4675.
Wills-Karp M, L.J., Xu X, Schofield B, Neben TY, Karp CL, Donaldson, DD. (1998). “Interleukin-13: Central Mediator of Allergic Asthma”. Science 282: 2258-2261.
Yang Gaoyun et al., “Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling”, Cytokine, vol. 28, No. 6 pp. 224-232, XP002542095 (2004).
Yuyama Noriko et al., Analysis of novel disease-related genes in bronchial asthma:, Cytokine, vol. 19, No. 6, pp. 287-296, XP002542097 (2002).
Lee et al., “Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types”, American Journal of Respiratory Cell and Molecular Biology, vol. 25, No. 4, pp. 474-485, XP002542098 (2001).
Syed et al, “Identification of interleukin-13 related biomarkers using peripheral blood mononuclear cells”, Biomarkers, Taylor and Francis, London, GB, vol. 12, No. 4, pp. 4140423 XP008110155 (2007).

Affiliated with

Also associated with

Rating

Compositions and methods for IL-13 biomarkers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for IL-13 biomarkers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for IL-13 biomarkers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2683849